We are live on ! Find out more
SCA

Spearhead Capital Advisors Portfolio holdings

AUM $92.3M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
–
AUM
$735M
AUM Growth
+$57.8M
Cap. Flow
+$11.1M
Cap. Flow %
1.5%
Top 10 Hldgs %
31.1%
Holding
195
New
10
Increased
148
Reduced
29
Closed
4

Top Buys

Rank Stock Value
1
GBDC icon
Golub Capital BDC
GBDC
+$2.33M
2
AAPL icon
Apple
AAPL
+$1.25M
3
BE icon
Bloom Energy
BE
+$903K
4
MLPB icon
ETRACS Alerian MLP Infrastructure Index ETN Series B due Apr 2 2040
MLPB
+$552K
5
CRM icon
Salesforce
CRM
+$365K

Top Sells

Rank Stock Value
1
KNSA icon
Kiniksa Pharmaceuticals
KNSA
+$2.15M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$601K
3
GNMK
GenMark Diagnostics, Inc
GNMK
+$576K
4
GLUU
Glu Mobile Inc.
GLUU
+$503K
5
MRNA icon
Moderna
MRNA
+$495K

Sector Composition

Rank Sector Weight
1 Technology 15.29%
2 Healthcare 12.02%
3 Consumer Staples 10.97%
4 Financials 10.35%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VFC icon
51
VF Corp
VFC
$5.63B
$7.78M 1.06%
94,778
+2,004
+2% +$167K
CLX icon
52
Clorox
CLX
$11.6B
$7.68M 1.04%
42,680
-433
-1% -$79K
BDX icon
53
Becton Dickinson
BDX
$45.6B
$7.68M 1.04%
32,352
+1,089
+3% +$261K
ECL icon
54
Ecolab
ECL
$78.1B
$7.53M 1.02%
36,575
+719
+2% +$156K
LTPZ icon
55
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$690M
$3.89M 0.53%
45,063
+524
+1% +$43.6K
KNSA icon
56
Kiniksa Pharmaceuticals
KNSA
$5.8B
$3.27M 0.45%
235,024
-141,821
-38% -$2.15M
GBDC icon
57
Golub Capital BDC
GBDC
$3.34B
$2.31M 0.31%
+150,000
New +$2.33M
IEF icon
58
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$1.91M 0.26%
16,548
+1,032
+7% +$118K
WIP icon
59
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$473M
$1.84M 0.25%
32,532
+340
+1% +$19.3K
IGF icon
60
iShares Global Infrastructure ETF
IGF
$10.9B
$1.73M 0.24%
38,120
+533
+1% +$24.9K
VGT icon
61
Vanguard Information Technology ETF
VGT
$139B
$1.3M 0.18%
26,016
-1,328
-5% -$62.6K
VGIT icon
62
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
$1.17M 0.16%
17,283
+1,858
+12% +$126K
BIV icon
63
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$1.16M 0.16%
12,863
+1,378
+12% +$123K
VCIT icon
64
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$1.15M 0.16%
12,112
+1,156
+11% +$109K
BE icon
65
Bloom Energy
BE
$60.6B
$1M 0.14%
+37,243
New +$903K
EMLP icon
66
First Trust North American Energy Infrastructure Fund
EMLP
$4.11B
$958K 0.13%
39,152
+324
+0.8% +$7.85K
TIP icon
67
iShares TIPS Bond ETF
TIP
$14.5B
$935K 0.13%
7,305
+85
+1% +$10.8K
VHT icon
68
Vanguard Health Care ETF
VHT
$18.1B
$867K 0.12%
3,506
-168
-5% -$40.1K
GOOGL icon
69
Alphabet (Google) Class A
GOOGL
$4.36T
$833K 0.11%
6,820
-1,700
-20% -$199K
IEI icon
70
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
$791K 0.11%
6,058
+11
+0.2% +$1.44K
EDV icon
71
Vanguard World Funds Extended Duration ETF
EDV
$3.22B
$786K 0.11%
5,807
+30
+0.5% +$3.88K
VTI icon
72
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$784K 0.11%
3,517
+32
+0.9% +$6.95K
VXF icon
73
Vanguard Extended Market ETF
VXF
$30.3B
$771K 0.1%
4,090
-272
-6% -$49.7K
BCRX icon
74
BioCryst Pharmaceuticals
BCRX
$2.28B
$722K 0.1%
45,686
+3,616
+9% +$49.1K
XPEL icon
75
XPEL
XPEL
$1.22B
$721K 0.1%
8,596
+639
+8% +$47.1K
1 2
3
4 5

Similar funds

AAM
Artha Asset Management Hoboken, New Jersey $90.3M AUM 27.66% 1-Year Est. Return
AEPBI
AH Equity Partners Bio III Menlo Park, California $95M AUM 50.1% 1-Year Est. Return
MW
Milestone Wealth Buffalo, New York $89.5M AUM 17.2% 1-Year Est. Return
SC
Sarissa Consulting Santa Monica, California $96.9M AUM 29.32% 1-Year Est. Return
NIM
NuWave Investment Management Parsippany, New Jersey $87.2M AUM 38.54% 1-Year Est. Return
WIM
Wilen Investment Management Bonita Springs, Florida $98.1M AUM 2.08% 1-Year Est. Return
LAM
LFS Asset Management San Ramon, California $99.1M AUM
EFEM
Eos Focused Equity Management New York $84.5M AUM 17.48% 1-Year Est. Return

Spearhead Capital Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Spearhead Capital Advisors held 195 positions worth $735M, up 8.5% from $677M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Spearhead Capital Advisors's Q2 2021 filing shows 10 new, 148 increased, 29 reduced and 4 closed positions. Its largest new stake was Golub Capital BDC: 150,000 shares worth $2.31M. The largest sale was Kiniksa Pharmaceuticals, an estimated $2.15M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Spearhead Capital Advisors's largest Q2 2021 buy was Golub Capital BDC: 150,000 shares worth $2.31M.
  • Spearhead Capital Advisors added most to Apple in Q2 2021, an estimated $1.25M increase.
  • Spearhead Capital Advisors's biggest Q2 2021 reduction was Kiniksa Pharmaceuticals, cutting an estimated $2.15M.
  • Spearhead Capital Advisors fully exited GenMark Diagnostics, Inc in Q2 2021, selling an estimated $576K.
  • Spearhead Capital Advisors's ten largest holdings make up 31% of its $735M portfolio in Q2 2021.
  • Spearhead Capital Advisors opened 10 new positions and closed 4 in Q2 2021.
  • Spearhead Capital Advisors's portfolio value rose 8.5% quarter-over-quarter to $735M.

Based on Spearhead Capital Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.